Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting IL-33. It inhibits IL-33 signaling through ST2 and RAGE/EGFR, reduces inflammation and epithelial dysfunction, and can be used to study chronic obstructive pulmonary disease.
Purity:
96.03%
CAS Number:
[2376858-66-9]
Target:
Interleukin|||Others
* VAT and and shipping costs not included. Errors and price changes excepted
